BPC-157
Body Protection Compound 157 — an experimental peptide studied for tissue repair and recovery.
BPC-157 is a lab-made peptide that’s become one of the most-talked-about recovery compounds online. Almost all the evidence behind it comes from animal studies, and it isn’t FDA-approved for anything. People still use it, mostly for stubborn tendon and joint injuries, so the practical questions are how to handle it properly and how not to get scammed buying it.
- Type
- 15-aa peptide
- Route
- Subcutaneous
- Typical dose
- 250–500 mcg/day
- Cycle
- 4–6 wks on
- Storage
- Mixed: ~4 wksSealed: months
- Status
- Not FDA-approved
What is BPC-157?
A 15-amino-acid synthetic peptide built from a sequence found in gastric juice, FDA-approved for nothing and known almost entirely from animal studies.
BPC-157 is short for “Body Protection Compound 157.” It’s a peptide, a short chain of amino acids, which are the same building blocks that make up every protein in your body. This one is 15 amino acids long. That’s the whole molecule, and there’s nothing exotic hiding behind the name.
The name comes from where the sequence was first found: researchers identified it inside a larger protein in gastric juice. But the 15-amino-acid fragment people buy today doesn’t exist on its own in the body. It’s a synthetic version, built in a lab from that sequence.
What is it studied for?
A 2025 systematic review found 35 animal studies and a single small human one, so read every claim as "studied for in rats."
Almost all of this research was done in animals, mostly rats and mice. A 2025 systematic review counted 35 animal studies and a single small human one. So “studied for” really means “studied for in rats,” and that distinction sits under every claim below.
The research has clustered in three areas:
How it works isn’t settled. The leading idea is straightforward: BPC-157 appears to help the body grow tiny new blood vessels, so an injured area gets more oxygen and nutrients, and to support the cells that lay down collagen, the scaffolding your body rebuilds itself with.
Why people use it
People reach for it for stubborn tendons, post-injury recovery, and gut health, but no human trial shows it does any of this.
Most people who try BPC-157 fall into one of a few situations. These are the reasons they reach for it, not evidence that it delivers:
- A nagging tendon or joint that hasn’t settled with rest and rehab — a stubborn Achilles, elbow, or knee.
- The recovery window after a hard injury, when waiting it out feels like not enough.
- Curiosity about gut health, where a lot of the early (and mostly animal) research has focused.
- The wear of hard, repeated training, and wanting to stay in it.
How to reconstitute BPC-157
Wipe the stopper, add bacteriostatic water slowly down the glass wall, and swirl rather than shake, since shaking can damage the peptide.
Your vial arrives as a small puck of dry powder. Before you can use it, you mix it into a liquid. That step is called reconstitution, and it’s where most first-timers get nervous. It’s simpler than it looks.
- Wipe the rubber stopper with an alcohol swab first, every time.
- Use bacteriostatic water, not plain sterile water and not saline. The trace of benzyl alcohol in it holds back bacteria, which matters because you’ll be drawing from the same vial for weeks.
- Add the water slowly, running it down the inside glass wall. Don’t blast it straight onto the powder.
- Don’t shake it. Swirl gently and let it dissolve on its own. Shaking foams the solution and can damage the peptide.
The water doesn’t change how much peptide is in the vial. It only sets the concentration, which decides how many units you draw. More water means a more dilute mix and a bigger draw for the same dose. You can’t ruin it with too much or too little; you only change the draw math, and that’s exactly what the calculator handles.
Calculate your exact BPC-157 reconstitution →Dose & units
No dose is FDA-approved; reported use is 250–500 mcg a day, often split twice daily and run 4–6 weeks on, 2–4 weeks off.
Typical range
Injected under the skin, the range reported most often is 250–500 mcg per day, frequently split into 250 mcg twice a day. (A microgram, or mcg, is a thousandth of a milligram.)
Starting out
Most people begin near the low end, around 250 mcg a day for the first week or two, and adjust from there. Starting low lets you notice any reaction before you’ve committed to more.
Cycling
Sources are fairly consistent that this is a time-limited course rather than something you run forever: commonly 4–6 weeks on, then 2–4 weeks off.
For the exact mark to draw to on your insulin syringe, don’t eyeball it. The calculator turns your vial size, water, and dose into the precise number of units.
Get your exact units →Storage
The sealed powder keeps for months at room temperature, but once mixed it goes in the fridge and is used within about four weeks.
That four-week limit is about contamination, not potency — the peptide itself often stays good well beyond it. Reconstitute with plain sterile water instead of bacteriostatic and you drop to a day or two, since there’s no preservative holding bacteria back.
Don’t freeze a reconstituted vial, keep it out of direct light, write the mix date on the label, and throw it out if the solution ever turns cloudy or discolored, whatever the date says.
Side effects & safety
Reported side effects are mild injection-site reactions, but it's banned by WADA since 2022 and the cancer-history caution is worth taking seriously.
The reported side effects are generally mild. That picture comes from animal studies and scattered clinic observation, not large human safety trials, so hold it loosely.
- Most common: mild, short-lived redness or irritation right at the injection site.
- Less often: some swelling at the site, mild nausea, or a little dizziness.
If you compete, BPC-157 has been on the WADA banned list since 2022 (it’s named under S0, non-approved substances). Using it is a doping violation.
And the biggest risk here isn’t really the molecule. It’s whether what’s in the vial is actually BPC-157, at the strength on the label. That comes down to where you buy it.
How to vet a source
In this unregulated market, demand a batch-specific third-party certificate of analysis and match its lot number to your vial, never a screenshot.
This is an unregulated market, and a real share of independently tested vials come back underdosed, impure, or not even the compound on the label. Where you buy matters more than almost anything else here. The one document that separates a real seller from a gamble is a certificate of analysis: a third-party lab’s report on what’s actually in the vial.
- An identity test (usually mass spectrometry) confirming the peptide is what the label says.
- A purity figure from HPLC, typically 98% or higher.
- A lot or batch number that matches the number printed on your vial.
- A named, independent accredited lab and a recent test date.
- There’s no COA, or it’s a generic image with no lot number.
- The “certificate” comes from the seller instead of a third-party lab.
- The lot number doesn’t match your vial, or there isn’t one at all.
- It’s a flat image you can’t trace back to the lab that issued it.
That’s the standard worth holding any seller to, ours included. Ask for the batch-specific COA before you buy, match the lot number to your vial, and don’t accept a screenshot in place of a traceable report.
See the Zapify compound catalog →Common questions about BPC-157
Is BPC-157 approved or proven to work in people?
BPC-157 or TB-500 — what’s the difference?
Why subcutaneous injection for BPC-157?
If it leaves the body in under 30 minutes, why would it help for days?
Why bacteriostatic water and not saline or sterile water?
References
- Rupa Health — BPC-157: Uses, Benefits, Dosage & Safety (reviewed by Dr. Sarah Daglis, ND)
- Peptides.org — BPC-157 Dosage (medically reviewed by Dimitar Marinov, PhD)
- Vasireddi et al. — BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (HSS Journal, 2025)
- Jóźwiak et al. — Multifunctionality and Possible Medical Application of BPC-157 (Pharmaceuticals, 2025)
- He L, Feng D, et al. — Pharmacokinetics of BPC-157 in rats and dogs (Frontiers in Pharmacology, 2022)
- USADA — BPC-157: Experimental Peptide Creates Risk for Athletes
- STAT News — How an unapproved drug became the next hot peptide (Feb 2026)
- Peptide Association — BPC-157 Peptide Therapy (Clinician’s Guide)
- Tucson Wellness MD — BPC-157 Dosage Guide
- Dr. Rogers Centers — BPC-157 Dosage: A Complete Guide
- BPC-157 as an Investigational Peptide Therapeutic (Pharmaceutics / MDPI, 2026)
